Document is current
Any future updates will be listed below
-
Authors
Kawamura, Maako
Shirota, Hidekazu
Niihori, Tetsuya http://orcid.org/0000-0002-2118-9776
Komine, Keigo
Takahashi, Masanobu
Takahashi, Shin
Miyauchi, Eisaku
Niizuma, Hidetaka
Kikuchi, Atsuo http://orcid.org/0000-0003-1002-8739
Tada, Hiroshi
Shimada, Muneaki
Kawamorita, Naoki
Kanamori, Masayuki
Sugiyama, Ikuko
Tsubata, Mari
Ichikawa, Hitotshi http://orcid.org/0000-0003-0142-2240
Yasuda, Jun http://orcid.org/0000-0002-3887-6871
Furukawa, Toru http://orcid.org/0000-0002-1083-2324
Aoki, Yoko http://orcid.org/0000-0002-1194-6972
Ishioka, Chikashi
- License Information
-
More Information
Article History
Received: 26 November 2022
Revised: 19 January 2023
Accepted: 12 February 2023
First Online: 20 February 2023
Competing interests
: Dr. Ishioka has received scholarship (incentive) endowments from Takeda, Daiichi-Sankyo, Ono, Asahi-Kasei Pharma, Taiho, and Chugai, as well as a research grant from Hitachi and Riken Genesis. Dr. Ichikawa has received research grants from Chugai Pharmaceutical, Eisai, Healios, and Ono Pharmaceutical, outside the submitted work. All remaining authors have declared no conflict of interest.
